High SPINK1 Expression Predicts Poor Prognosis and Promotes Cell Proliferation and Metastasis of Hepatocellular Carcinoma

References

• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086.
   PubMed Web of Science ®Google Scholar
• Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–1255. doi:10.1016/S0140-6736(11)61347-0.
   PubMed Web of Science ®Google Scholar
• Fukuda S, Itamoto T, Nakahara H, et al. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology. 2005;52(64):1163–1167.
   PubMedGoogle Scholar
• Stenman UH. Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development. Asian J Androl. 2011;13(4):628–629. doi:10.10.38/aja.2011.45.
   Google Scholar
• Huhtala ML, Pesonen K, Kalkkinen N, Stenman UH. Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem. 1982;257(22):13713–13716.
   PubMed Web of Science ®Google Scholar
• Kazal LA, Spicer DS, Brahinsky RA. Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas. J Am Chem Soc. 1948;70(9):3034–3040. doi:10.1021/ja01189a060.
   PubMed Web of Science ®Google Scholar
• Itkonen O, Stenman UH. TATI as a biomarker. Clin Chim Acta. 2014;431:260–269. doi:10.1016/j.cca.2014.02.014.
   PubMed Web of Science ®Google Scholar
• Gaber A, Johansson M, Stenman UH, et al. High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. Br J Cancer. 2009;100(10):1540–1548. doi:10.1038/sj.bjc.6605047.
   PubMed Web of Science ®Google Scholar
• Rasanen K, Itkonen O, Koistinen H, Stenman UH. Emerging Roles of SPINK1 in Cancer. Clin Chem. 2016;62(3):449–457. doi:10.1373/clinchem.2015.241513.
   PubMed Web of Science ®Google Scholar
• Wiksten JP, Lundin J, Nordling S, et al. High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. Histopathology. 2005;46(4):380–388. doi:10.1111/j.1365-2559.2005.02073.x.
   PubMed Web of Science ®Google Scholar
• Tiwari R, Pandey SK, Goel S, et al. SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression. Oncogenesis. 2015;4(8):e162–e162. doi:10.1038/oncsis.2015.23.
   PubMed Web of Science ®Google Scholar
• Chen YT, Tsao SC, Yuan SS, Tsai HP, Chai CY. Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker. Pathol Oncol Res. 2015;21(4):1201–1208. doi:10.1007/s12253-015-9949-0.
   PubMed Web of Science ®Google Scholar
• Gouyer V, Fontaine D, Dumont P, et al. Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells. Oncogene. 2008;27(29):4024–4033. doi:10.1038/onc.2008.42.
   PubMed Web of Science ®Google Scholar
• Flavin R, Pettersson A, Hendrickson WK, et al. SPINK1 protein expression and prostate cancer progression. Clin Cancer Res. 2014;20(18):4904–4911. doi:10.1158/1078-0432.CCR-13-1341.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang L, Su B, et al. Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer. Prostate. 2014;74(7):689–701. doi:10.1002/pros.22787.
   PubMed Web of Science ®Google Scholar
• Soon WW, Miller LD, Black MA, et al. Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer. EMBO Mol Med. 2011;3(8):451–464. doi:10.1002/emmm.201100150.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Ha YJ, Na Kang Y, et al. The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma. PLoS One. 2013;8(11):e81540. doi:10.1371/journal.pone.0081540.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang J, Zhang L, et al. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma. Hepatology. 2016;63(4):1240–1255. doi:10.1002/hep.28409.
   PubMed Web of Science ®Google Scholar
• Lyytinen I, Lempinen M, Nordin A, et al. Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-beta (hCGbeta) in patients with hepatocellular carcinoma. Scand J Gastroenterol. 2013;48(9):1066–1073. doi:10.3109/00365521.2013.805810.
   PubMed Web of Science ®Google Scholar
• Hass HG, Jobst J, Vogel U, Scheurlen M, Nehls O. Overexpression of Tumor-Associated Trypsin Inhibitor (SPINK1/TATI) in Hepatitis C-Associated Hepatocellular Carcinoma: Potential Implications for Viral Hepatocarcinogenesis. Oncol Res Treat. 2014;37(12):732–738. doi:10.1159/000369151.
   PubMed Web of Science ®Google Scholar
• Marshall A, Lukk M, Kutter C, et al. Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker. PLoS One. 2013;8(3):e59459. doi:10.1371/journal.pone.0059459.
   PubMed Web of Science ®Google Scholar
• Lee YC, Pan HW, Peng SY, et al. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma. Eur J Cancer. 2007;43(4):736–744. doi:10.1016/j.ejca.2006.11.020.
   PubMed Web of Science ®Google Scholar
• Hai-Yan Y, Chao-Jie G, Yi F, Da-Dao J, Lu LG. Serine protease inhibitor Kazal type 1(SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway. J Dig Dis. 2017; 18(6):349–358. doi:10.1111/1751-2980.12486..
   PubMed Web of Science ®Google Scholar
• Ozaki N, Ohmuraya M, Hirota M, et al. Serine Protease Inhibitor Kazal Type 1 Promotes Proliferation of Pancreatic Cancer Cells through the Epidermal Growth Factor Receptor. Mol Cancer Res. 2009;7(9):1572–1581. doi:10.1158/1541-7786.MCR-08-0567.
   PubMed Web of Science ®Google Scholar
• Xu L, Lu C, Huang Y, et al. SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker. BMB Rep. 2018;51(12):648–653. doi:10.5483/BMBRep.2018.51.12.205.
   PubMed Web of Science ®Google Scholar
• Shek FH, Luo R, Lam B, et al. Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/beta-catenin axis in hepatocellular carcinoma. Cell Oncol. 2017;40(5):443–456. doi:10.1007/s13402-017-0332-x.
   Web of Science ®Google Scholar
• Ateeq B, Tomlins SA, Laxman B, et al. Therapeutic targeting of SPINK1-positive prostate cancer. Sci Transl Med. 2011;3(72):17r–72r. doi:10.1126/scitranslmed.3001498.
   Web of Science ®Google Scholar
• Cui J, Hu YF, Feng XM, et al. EGFR inhibitors and autophagy in cancer treatment. Tumor Biol. 2014;35(12):11701–11709. doi:10.1007/s13277-014-2660-z.
   PubMedGoogle Scholar
• Maddocks O, Athineos D, Cheung EC, et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature. 2017;544(7650):372–376. doi:10.1038/nature22056.
   PubMed Web of Science ®Google Scholar
• Amelio I, Cutruzzola F, Antonov A, Agostini M, Melino G. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39(4):191–198. doi:10.1016/j.tibs.2014.02.004.
   PubMed Web of Science ®Google Scholar
• Bruns H, Kazanavicius D, Schultze D, et al. Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells. Amino Acids. 2016;48(11):2549–2558. doi:10.1007/s00726-016-2278-0.
   PubMed Web of Science ®Google Scholar
• Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111–128. doi:10.1038/nrgastro.2017.119.
   PubMed Web of Science ®Google Scholar
• Whitcomb DC. How to think about SPINK and pancreatitis. Am J Gastroenterology. 2002;97(5):1085–1088. doi:10.1111/j.1572-0241.2002.05697.x.
   PubMed Web of Science ®Google Scholar